Background Pathogenesis of progressive liver fibrosis in biliary atresia after successful
portoenterostomy remains unclear. We related hepatic expression of transforming growth …

Background In biliary atresia mechanisms of progressive liver injury leading to need of liver
transplantation after successful portoenterostomy remain unknown. A better understanding …

BACKGROUND/PURPOSE: Transforming growth factor-beta (TGF-β) 1 and 2 and their
receptors TβR-I, TβR-II, and TβR-III are powerful profibrogenic mediators in the body. Their …

The molecular mechanisms underlying progressive liver fibrosis following surgical treatment
of biliary atresia (BA) remain unclear. Our aim was to address hepatic gene and protein …

Extrahepatic biliary atresia is a severe neonatal liver disease resulting from a sclerosing
cholangiopathy of unknown etiology. Although biliary obstruction may be surgically …

Purpose: Biliary atresia (BA) is the most common indication of liver transplantation in
children. Pathogenesis of hepatic fibrosis, which is a prominent feature of BA, remains …

Successful portoenterostomy (SPE) improves the short‐term outcome of patients with biliary
atresia (BA) by relieving cholestasis and extending survival with native liver. Despite SPE …

Connective tissue growth factor (CTGF) is a newly described protein that stimulates
transforming growth factor-β1 (TGF-β1). We evaluated the expression of CTGF mRNA in …

Abstract Background and Aim: Biliary atresia (BA) is a serious liver disease in children.
Since transforming growth factor-β1 (TGF-β1) and epidermal growth factor (EGF) are …

Serum FGF19 predicts outcomes of Kasai portoenterostomy in b... : Hepatology Serum FGF19
predicts outcomes of Kasai portoenterostomy in biliary atresia : Hepatology AASLD Publications …